Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.21M | 4.33M | 4.34M | 4.34M | 3.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.21M | 4.33M | 4.34M | 4.34M | 3.30M |
| Cost of Revenue | 1.42M | 1.46M | 634.60K | 633.30K | 1.04M |
| Gross Profit | 2.79M | 2.87M | 3.71M | 3.70M | 2.26M |
| SG&A Expenses | 3.30M | 3.39M | 3.78M | 3.77M | 2.82M |
| Depreciation & Amortization | -- | -- | 516.30K | 515.30K | -- |
| Other Operating Expenses | 853.00K | 877.10K | 519.30K | 518.20K | 824.70K |
| Total Operating Expenses | 5.97M | 6.13M | 5.45M | 5.44M | 5.15M |
| Operating Income | -1.75M | -1.80M | -1.11M | -1.11M | -1.85M |
| Income Before Tax | -1.76M | -1.81M | -1.04M | -1.04M | -1.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.76M | -1.81M | -1.04M | -1.04M | -1.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.76M | -1.81M | -1.04M | -1.04M | -1.83M |
| EBIT | -1.75M | -1.80M | -1.11M | -1.11M | -1.85M |
| EBITDA | -1.69M | -1.74M | -591.40K | -590.20K | -1.77M |
| EPS Basic | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 229.53M | 229.53M | 217.60M | 217.60M | 190.68M |
| Average Diluted Shares Outstanding | 229.53M | 229.53M | 217.60M | 217.60M | 190.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |